Fig. 3From: Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcomaTAS-115 suppresses phosphorylation of c-MET and PDGFRα, as well as their downstream effectors. a Yamato-SS cells (c-MET-dependent SS cells) were treated with 0.001–10 μM of TAS-115 or control (0.1% DMSO) for 3 h. b SYO-1 and HS-SY-II cells (PDGFRα-dependent SS cells) were treated with 0.001–10 μM of TAS-115 or control (0.1% DMSO) for 3 hBack to article page